We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Ametek
AME
$53.2B
| $299K | ﹤0.01% |
2,033
-4,635
| -70% | -$634K |
|
|
JNPR
1577
DELISTED
Juniper Networks
JNPR
| $298K | ﹤0.01% |
8,351
+6,731
| +415% | +$210K |
|
1578
Werner Enterprises
WERN
$2.15B
| $298K | ﹤0.01% |
6,258
-17,269
| -73% | -$791K |
|
1579
OneMain Financial
OMF
$6.97B
| $297K | ﹤0.01% |
5,936
+1,690
| +40% | +$89.4K |
|
1580
Codexis
CDXS
$147M
| $296K | ﹤0.01% |
+9,475
| New | +$312K |
|
1581
Welltower
WELL
$169B
| $294K | ﹤0.01% |
3,426
+1,406
| +70% | +$117K |
|
1582
Fidelity National Financial
FNF
$11.5B
| $290K | ﹤0.01% |
5,777
+63
| +1% | +$3.01K |
|
1583
Zebra Technologies
ZBRA
$16.1B
| $286K | ﹤0.01% |
480
-222
| -32% | -$126K |
|
1584
Eversource Energy
ES
$25.6B
| $284K | ﹤0.01% |
3,120
-85
| -3% | -$7.31K |
|
1585
Lennar Class B
LEN.B
$18.5B
| $284K | ﹤0.01% |
3,124
+346
| +12% | +$28.5K |
|
1586
Dycom Industries
DY
$8.67B
| $282K | ﹤0.01% |
3,004
-4,696
| -61% | -$397K |
|
1587
International Flavors & Fragrances
IFF
$21.5B
| $282K | ﹤0.01% |
1,874
-196
| -9% | -$28.6K |
|
1588
Entergy
ETR
$48.9B
| $280K | ﹤0.01% |
4,976
-168
| -3% | -$8.82K |
|
1589
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
| $277K | ﹤0.01% |
3,180
-53,377
| -94% | -$4.63M |
|
1590
Modine Manufacturing
MOD
$9.62B
| $277K | ﹤0.01% |
27,427
-135,951
| -83% | -$1.51M |
|
1591
Corteva
CTVA
$54B
| $274K | ﹤0.01% |
5,803
-212
| -4% | -$9.65K |
|
1592
Organon & Co
OGN
$3.59B
| $272K | ﹤0.01% |
8,924
+7,760
| +667% | +$253K |
|
|
GTHX
1593
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $271K | ﹤0.01% |
26,516
-33,617
| -56% | -$428K |
|
1594
Pentair
PNR
$9.01B
| $268K | ﹤0.01% |
3,661
-69
| -2% | -$5.08K |
|
1595
Willis Towers Watson
WTW
$29.1B
| $268K | ﹤0.01% |
1,130
+738
| +188% | +$175K |
|
1596
Caesars Entertainment
CZR
$6.05B
| $265K | ﹤0.01% |
2,834
+1,246
| +78% | +$126K |
|
1597
PENN Entertainment
PENN
$2.37B
| $265K | ﹤0.01% |
5,086
+3,816
| +300% | +$231K |
|
1598
Cincinnati Financial
CINF
$26.2B
| $263K | ﹤0.01% |
2,306
-235
| -9% | -$27.8K |
|
|
CBAY
1599
DELISTED
Cymabay Therapeutics
CBAY
| $262K | ﹤0.01% |
77,403
+77,361
| +184,193% | +$294K |
|
1600
Corning
GLW
$124B
| $260K | ﹤0.01% |
6,983
-103
| -1% | -$3.86K |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.